Alivus Life Sciences Ltd (ALIVUS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003513, "name": "Alivus Life", "stock_name": "Alivus Life", "full_name": "Alivus Life Sciences Ltd", "name_url": "stocks-analysis/alivus-life", "exchange": 1, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "947.40", "chg": 25.5, "chgp": "2.77%", "dir": 1, "prev_price": "921.90", "mcapval": "11,591.00 Cr", "mcap": "Small Cap", "scripcode": 543322, "symbol": "ALIVUS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE03Q201024", "curr_date": "Feb 03", "curr_time": "", "bse_nse_vol": "61.77 k", "exc_status": "Active", "traded_date": "Feb 03, 2026", "traded_date_str": "2026 02 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Alivus Life Sciences Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-3812411", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_mojoScore_3812411.png", "date": "2026-01-31 10:10:48", "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Why is Alivus Life Sciences Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alivus-life-sciences-ltd-fallingrising-3808544", "imagepath": "", "date": "2026-01-29 00:58:30", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Context</strong></p>\n<p>Alivus Life Sciences has outperformed the broader market and its sector peers in recent trading sessions. Over the past week, the stock surged by 8.27%, significantly eclipsing the Sensex’s modest 0.53% gain. Even on a one-month basis, the stock posted a positive return of 3.07%, contrasting with the Sensex’s decline of 3.17%. Year-to-date, Alivus Life Sciences has managed a 1.94% increase, while the benchmark index fell by 3.37%. These figures underscore the stock’s resilience amid a volatile market environment.</p>\n<p>On the day of the price rise, the stock outperformed its sector by 4.85%, reaching an intraday high of ₹937.45, representing a 5.6% increase. Notably, the stock has been on a three-day consecutive gain streak, accumu..." }, { "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3806750", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_technicaldot_3806750.png", "date": "2026-01-28 08:00:36", "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical parameters, signalling a nuanced change in price momentum. While some indicators suggest mild bullishness, others remain bearish, reflecting a complex outlook for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3805009", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_technicaldot_3805009.png", "date": "2026-01-27 08:03:19", "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest day gain of 1.53%, the stock’s broader technical landscape reveals a complex interplay of bullish and bearish signals, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector." }, { "title": "Alivus Life Sciences Ltd Gains 0.20%: 4 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-gains-020-4-key-factors-driving-the-week-3803196", "imagepath": "", "date": "2026-01-24 11:03:47", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 19:</strong> Technical downgrade triggers bearish momentum</p>\n <p><strong>Jan 21:</strong> Mixed technical signals amid modest price decline</p>\n <p><strong>Jan 22:</strong> Quarterly results announced showing strong profit growth</p>\n <p><strong>Jan 23:</strong> Stock rallies 2.36% on strong quarterly performance</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.870.30</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.882.1..." }, { "title": "Are Alivus Life Sciences Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-alivus-life-sciences-ltd-latest-results-good-or-bad-3802473", "imagepath": "", "date": "2026-01-23 19:17:55", "description": "Alivus Life Sciences Ltd's latest financial results for the quarter ending December 2025 reflect a notable performance, characterized by record-breaking operational metrics. The company achieved its highest-ever quarterly revenue of ₹672.89 crores, marking a sequential growth of 14.44% from the previous quarter, which contrasts sharply with the modest decline observed in the prior quarter. This growth indicates a strong rebound in demand or successful product launches.\n\nThe operating margin expanded significantly to 34.37%, representing a substantial improvement of 390 basis points from the previous quarter's 30.47%. This margin expansion, alongside a net profit of ₹150.26 crores, which grew by 15.56% sequentially, suggests enhanced operational efficiency and effective cost management.\n\nDespite these strong operational results, the company faces challenges in the broader market context, as its stock trades ..." }, { "title": "Alivus Life Sciences Ltd Reports Strong Quarterly Growth Amid Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-reports-strong-quarterly-growth-amid-mixed-market-returns-3800938", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_fintrenddot_3800938.png", "date": "2026-01-23 08:00:16", "description": "Alivus Life Sciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, signalling a positive shift in its growth trajectory. The company reported record-breaking revenue and profitability metrics, reflecting a turnaround from a previously flat financial trend to a robust positive momentum." }, { "title": "Alivus Life Sciences Q3 FY26: Robust Profit Growth Amid Technical Headwinds", "link": "https://www.marketsmojo.com/news/result-analysis/alivus-life-sciences-q3-fy26-robust-profit-growth-amid-technical-headwinds-3800649", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_quaterlyResult_3800649.png", "date": "2026-01-22 16:38:10", "description": "Alivus Life Sciences Ltd., a small-cap pharmaceutical company with a market capitalisation of ₹10,551 crores, delivered a strong financial performance in Q3 FY26, posting net profit of ₹150.26 crores—a sequential increase of 15.58% and year-on-year growth of 9.71%. Despite this operational strength, the stock has faced significant headwinds, trading at ₹865.25 as of January 22, 2026, down 23.03% over the past year and currently in a mildly bearish technical trend." }, { "title": "Alivus Life Sciences Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3797755", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_technicaldot_3797755.png", "date": "2026-01-21 08:04:46", "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish territory. Despite some bullish cues on shorter-term charts, the overall technical landscape remains cautious, reflecting the stock’s recent underperformance relative to the broader market and sector peers." } ], "total": 256, "sid": "1003513", "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25", "dt": "2025-09-01", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Jan 19: Technical downgrade triggers bearish momentum

Jan 21: Mixed technical signals amid modest price decline

Jan 22: Quarterly results announced showing strong profit growth

Jan 23: Stock rallies 2.36% on strong quarterly performance

Read full news article

Are Alivus Life Sciences Ltd latest results good or bad?

2026-01-23 19:17:55

Alivus Life Sciences Ltd's latest financial results for the quarter ending December 2025 reflect a notable performance, characterized by record-breaking operational metrics. The company achieved its highest-ever quarterly revenue of ₹672.89 crores, marking a sequential growth of 14.44% from the previous quarter, which contrasts sharply with the modest decline observed in the prior quarter. This growth indicates a strong rebound in demand or successful product launches. The operating margin expanded significantly to 34.37%, representing a substantial improvement of 390 basis points from the previous quarter's 30.47%. This margin expansion, alongside a net profit of ₹150.26 crores, which grew by 15.56% sequentially, suggests enhanced operational efficiency and effective cost management. Despite these strong operational results, the company faces challenges in the broader market context, as its stock trades ...

Read full news article

Alivus Life Sciences Ltd Reports Strong Quarterly Growth Amid Mixed Market Returns

2026-01-23 08:00:16

Alivus Life Sciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, signalling a positive shift in its growth trajectory. The company reported record-breaking revenue and profitability metrics, reflecting a turnaround from a previously flat financial trend to a robust positive momentum.

Read full news article

Alivus Life Sciences Q3 FY26: Robust Profit Growth Amid Technical Headwinds

2026-01-22 16:38:10

Alivus Life Sciences Ltd., a small-cap pharmaceutical company with a market capitalisation of ₹10,551 crores, delivered a strong financial performance in Q3 FY26, posting net profit of ₹150.26 crores—a sequential increase of 15.58% and year-on-year growth of 9.71%. Despite this operational strength, the stock has faced significant headwinds, trading at ₹865.25 as of January 22, 2026, down 23.03% over the past year and currently in a mildly bearish technical trend.

Read full news article

Alivus Life Sciences Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-21 08:04:46

Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish territory. Despite some bullish cues on shorter-term charts, the overall technical landscape remains cautious, reflecting the stock’s recent underperformance relative to the broader market and sector peers.

Read full news article